Effectiveness of convalescent plasma therapy in severe COVID-19 patients
중증 코로나19 환자에서 회복기 혈장 요법의 효과
530
Published on
Journal: Proceedings of the National Academy of Sciences of [Category] Communicable Disease, COVID-19, SARS,
Journal: Proceedings of the National Academy of Sciences of [Category] Communicable Disease, COVID-19, SARS,
[키워드] Absorption
addition
Antibody titers
antiviral agent
Antiviral agents
approved
C-reactive protein
clinical benefit
Clinical outcome
clinical outcomes
clinical symptom
Clinical symptoms
convalescent plasma
Convalescent plasma therapy
coronavirus disease
Coronavirus disease 2019
COVID-19
criteria
disappearance
Donor
dose
Endpoint
enrolled
feasibility
FIVE
global health
Health
IMPROVE
laboratory parameter
Laboratory parameters
lung lesion
lung lesions
lymphocyte
Lymphocyte count
maintain
median time
Neutralizing
Neutralizing antibodies
neutralizing antibody
Neutralizing antibody titer
neutralizing antibody titers
Novel coronavirus
novel coronavirus disease
optimal dose
oxyhemoglobin
oxyhemoglobin saturation
parameter
Patient
pilot project
primary endpoint
Radiological examinations
randomized trial
Seven
severe adverse effect
severe COVID-19
severe COVID-19 patient
Severe patient
severe patients
Significance
significantly
supportive care
the patient
therapy
transfused
transfusion
Treatment
Treatment outcome
trials
undetectable
Viral
Viral load
Viral RNA
Viremia
[DOI] 10.1073/pnas.2004168117 PMC 바로가기 [Article Type] 530
[DOI] 10.1073/pnas.2004168117 PMC 바로가기 [Article Type] 530